FDA Inspection 1178378 — UnityPoint Health Des Moines IRB
The FDA completed an inspection of UnityPoint Health Des Moines IRB on August 24, 2022 in Des Moines, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 24, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Des Moines, IA (United States)
Additional Details
IRB